FCI-Glioblastoma: MRI-guided treatment after standard therapy
Part of Cancer clinical trials.
This trial is testing a new approach for people with glioblastoma who have just completed standard radiation and chemotherapy. It aims to see if adding a special MRI scan can help guide treatment decisions and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have finished your first round of radiation and chemotherapy (temozolomide) for glioblastoma within the last 4 weeks
- You are between 18 and 70 years old
- Your doctor expects you to live at least 12 more weeks
- You can have an MRI scan that lasts up to 1 hour
- You have been on a stable or decreasing dose of steroids for at least 5 days
- You are able to understand spoken and written English and give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This trial tests whether adding a precise, MRI-guided radiation treatment to tumor-treating electric fields (TTFields) can help people with recurrent glioblastoma. You may qualify if your tumor has come back 1 to 3 times after standard therapy and you haven't had certain prior treatments.
This trial tests a special MRI technique to help surgeons remove more of a glioblastoma brain tumor during surgery. The goal is to see if this approach helps people live longer.
This trial tests whether adding a special type of radiofrequency electromagnetic field treatment to standard chemotherapy and radiation therapy helps people with newly diagnosed glioblastoma. It is for patients who are planning to receive standard treatment and have had surgery to remove the tumor.
This study tests a new way to plan and deliver radiation therapy for glioblastoma (an aggressive brain tumor) using special MRI scans to target cancer cells more precisely. The goal is to improve treatment effectiveness while reducing harm to healthy brain tissue.
This study tests how best to measure and track glioblastoma treatment while using MRI (a body scanner) to guide radiation. It may help improve how doctors assess the radiation response during therapy.
Hear when a new Glioblastom WHO Grade 4 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.